| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |